Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells

Nature

Volumn 423, Issue 6937, 2003, Pages 255-260

  Lessard, Julie ^a   Sauvageau, Guy ^a,b  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE CONTROL; GENES; GROWTH KINETICS; ONCOLOGY; PATIENT TREATMENT; TRANSPLANTS;

APOPTOSIS; CANCER BIOLOGY; LEUKAEMIA; PROLIFERATIVE ACTIVITY;

TUMORS;

CANCER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BMI 1 GENE; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CLONE; CONTROLLED STUDY; GENE; GENE EXPRESSION; LEUKEMIA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEM CELL; ANIMAL; CANCER STEM CELL; CANCER TRANSPLANTATION; CELL CLONE; CELL DIVISION; CYTOLOGY; GENE DELETION; GENETICS; GENOTYPE; LEUKEMIA; LIVER; METABOLISM; PATHOLOGY; PRENATAL DEVELOPMENT;

ANIMALIA;

BMI1 PROTEIN, MOUSE; NUCLEAR PROTEIN; ONCOPROTEIN; REPRESSOR PROTEIN;

ANIMALS; CELL DIVISION; CLONE CELLS; GENE DELETION; GENOTYPE; LEUKEMIA; LIVER; MICE; NEOPLASM TRANSPLANTATION; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS; REPRESSOR PROTEINS; STEM CELLS; TUMOR STEM CELLS;

EID: 0037673984     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/nature01572     Document Type: Article

References (24)

1. Bonnet, D. & Dick, J. E. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature Med. 3, 730-737 (1997).
2. Lapidot, T. et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367, 645-648 (1994).
3. Appelbaum, F. R., Rowe, J. M., Radich, J. & Dick, J. E. Acute myeloid leukemia. Hematology (Am. Soc. Hematol. Educ. Program), 62-86 (2001).
4. Jordan, C. T. et al. The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells. Leukemia 14, 1777-1784 (2000).
5. Testa, U. et al. Elevated expression of IL-3Rα in acute myelogenous leukemia is associated with enhanced blast proliferation, increased cellularity, and poor prognosis. Blood 100, 2980-2988 (2002).
6. Lessard, J., Baban, S. & Sauvageau, G. Stage-specific expression of polycomb group genes in human bone marrow cells. Blood 91, 1216-1224 (1998).
7. Lessard, J. et al. Functional antagonism of the Polycomb-Group genes ccd and Bmi1 in hemopoietic cell proliferation. Genes Dev. 13, 2691-2703 (1999).
8. Park, I. K. et al. Differential gene expression profiling of adult murine hematopoietic stem cells. Blood 99, 488-498 (2002).
9. van der Lugt, N. M. et al. Posterior transformation, neurological abnormalities, and severe hematopoietic defects in mice with a targeted deletion of the bmi-1 proto-oncogene. Genes Dev. 8, 757-759 (1994).
10. Kroon, E. et al. Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b. EMBO J. 17, 3714-3725 (1998).
11. Borrow, J. et al. The t(7;11)(p15;p15) translocation in acute myeloid leukaemia fuses the genes for nucleoporin NUP98 and class I homeoprotein HOXA9. Nature Genet. 12, 159-167 (1996).
12. Nakamura, T. et al. Fusion of the nucleoporin gene NUP98 to HOXA9 by the chromosome translocation t(7;11)(p15;p15) in human myeloid leukaemia. Nature Genet. 12, 154-158 (1996).
13. Jacobs, J. J., Kieboom, K., Marino, S., DePinho, R. A. & van Lohuizen, M. The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature 397, 164-168 (1999).
14. Weber, H. O., Samuel, T., Rauch, P. & Funk, J. O. Human p14(ARF)-mediated cell cycle arrest strictly depends on intact p53 signaling pathways. Oncogene 21, 3207-3212 (2002).
15. Kamijo, T. et al. Functional and physical interactions of the ARF tumour suppressor with p53 and Mdm2. Proc. Natl Acad. Sci. USA 95, 8292-8297 (1998).
16. Porcher, C. et al. The T cell leukemia oncoprotein SCL/tal-1 is essential for development of all hematopoietic lineages. Cell 86, 47-57 (1996).
17. Sauvageau, G. et al. Overexpression of HOXB4 in hematopoietic cells causes the selective expansion of more primitive populations in vitro and in vivo. Genes Dev. 9, 1753-1765 (1995).
18. Vonlanthen, S. et al. The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression. Br. J. Cancer 84, 1372-1376 (2001).
19. Dimri, G. P. et al. The Bmi-1 oncogene induces telomerase activity and immortalizes human mammary epithelial cells. Cancer Res. 62, 4736-4745 (2002).
20. Thorsteinsdottir, U. et al. Overexpression of the myeloid leukemia-associated Hoxa9 gene in bone marrow cells induces stem cell expansion. Blood 99, 121-129 (2002).
21. Sauvageau, G. et al. Overexpression of HOXB3 in hematopoietic cells causes defective lymphoid development and progressive myeloproliferation. Immunity 6, 13-22 (1997).
22. Krosl, J. et al. Cellular proliferation and transformation induced by HOXB4 and HOXB3 proteins involves cooperation with PBX1. Oncogene 16, 3403-3412 (1998).
23. Brady, G., Barbara, M. & Iscove, N. N. Representative in vitro cDNA amplification from individual hemopoietic cells and colonies. Mol. Cell. Biol. 2, 17-25 (1990).
24. Park, I.-K. et al. Bmi-1 is required for maintenance of adult self-renewing haematopoietic cells. Nature 423, 302-305 (2003).